Loading...
AirSculpt Q1 2025 Earnings Report
AirSculpt Technologies reported its first quarter fiscal 2025 results, showing a decline in revenue and net income compared to the previous year, but with profitability strengthening sequentially from the fourth quarter of 2024.
Key Takeaways
AirSculpt Technologies reported a decline in revenue and net income for the first quarter of fiscal year 2025 compared to the same period in 2024, with revenue decreasing by 17.3% to $39.4 million and a net loss of $2.8 million. Despite the decline, the company noted strengthened profitability compared to the fourth quarter of 2024 due to cost reduction initiatives and expense discipline.
First quarter 2025 revenue declined 17.3% to $39.4 million from $47.6 million in the fiscal year 2024 first quarter.
The company reported a net loss of $2.8 million for the quarter, compared to net income of $6.0 million in the fiscal year 2024 first quarter.
Adjusted EBITDA was $3.8 million, down from $7.3 million in the fiscal year 2024 first quarter.
Case volume decreased by 17.9% to 3,076 for the first quarter of 2025, from 3,746 in the prior year.
AirSculpt
AirSculpt
Forward Guidance
AirSculpt Technologies projects full year 2025 revenue to be approximately $160 million to $170 million and adjusted EBITDA to be approximately $16 million to $18 million.
Positive Outlook
- Expects disciplined execution of business imperatives to drive sequential improvement in revenue throughout the year.
- Continued focus on increasing lead generation, consultations, and case conversion with enhanced marketing and sales generation efforts.
- Anticipates the introduction of an expanded range of financing options to further assist in achieving growth goals.
- Piloting skin tightening as a standalone offering, which has seen increasing interest and is uniquely positioned to capitalize on this opportunity.
- Believes AirSculpt is an attractive business with a competitive moat ripe for disruption, with best years ahead for shareholders.
Challenges Ahead
- Acknowledges operating in an uncertain environment.
- Future results could be affected by inability to sell equity or other securities at a desired time.
- Risk of inability to raise capital on commercially reasonable terms, or future financings diluting stockholders or restricting business.
- Potential failure to stabilize same-store performance.
- Risk of increased operating expenses due to rising inflation and increased competition in the weight loss and obesity solutions market.